Evarrest

human fibrinogen / human thrombin

  • Email
  • Help

About

The marketing authorisation for Evarrest has been withdrawn at the request of the marketing-authorisation holder.

Name Language First published Last updated
Evarrest : EPAR - Summary for the public BG = bălgarski 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public ES = español 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public CS = čeština 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public DA = dansk 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public DE = Deutsch 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public ET = eesti keel 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public EL = elliniká 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public EN = English 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public FR = français 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public IT = italiano 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public LV = latviešu valoda 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public LT = lietuvių kalba 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public HU = magyar 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public MT = Malti 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public NL = Nederlands 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public PL = polski 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public PT = português 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public RO = română 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public SK = slovenčina 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public SL = slovenščina 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public FI = suomi 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public SV = svenska 2013-10-07 2018-04-03
Evarrest : EPAR - Summary for the public HR = Hrvatski 2013-10-07 2018-04-03

This EPAR was last updated on 03/04/2018 .

Authorisation details

Product details

Product details for Evarrest
NameEvarrest
Agency product numberEMEA/H/C/002515
Active substance

human fibrinogen / human thrombin

International non-proprietary name (INN) or common name

human fibrinogen / human thrombin

Therapeutic area Hemostasis
Anatomical therapeutic chemical (ATC) code B02BC30
Additional monitoring

This medicine is under additional monitoring. This means that it is being monitored even more intensively than other medicines. For more information, see medicines under additional monitoring.

Publication details

Publication details for Evarrest
Marketing-authorisation holder

Omrix Biopharmaceuticals N. V.

Revision4
Date of issue of marketing authorisation valid throughout the European Union25/09/2013

Contact address:

Omrix Biopharmaceuticals N. V.
Leonardo Da Vinci Laan 15 
1831 Diegem 
Belgium

Product information

Product information

15/11/2017  Evarrest -EMEA/H/C/002515 -II/0027/G

Name Language First published Last updated
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - Product Information HR = Hrvatski 2013-10-07 2018-04-03

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.


Name Language First published Last updated
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03
Evarrest : EPAR - All Authorised presentations HR = Hrvatski 2013-10-07 2018-04-03

Pharmacotherapeutic group

Haemostatic combinations

Therapeutic indication

 Supportive treatment in adult surgery where standard surgical techniques are insufficient (see section 5.1):

-   for improvement of haemostasis.

Assessment History

Changes since initial authorisation of medicine

Name Language First published Last updated
Evarrest : EPAR - Procedural steps taken and scientific information after authorisation HR = Hrvatski 2014-10-06 2018-04-03

Initial marketing-authorisation documents

Name Language First published Last updated
Evarrest : EPAR - Public assessment report HR = Hrvatski 2013-10-07 2018-04-03
CHMP summary of positive opinion for Evarrest HR = Hrvatski 2013-06-28 2018-04-03

Withdrawn

This medicine is now withdrawn from use in the European Union

More information on Evarrest